BillionToOne, Inc.
BLLN
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.54B
Close$
$116.62
18.1% upside
Current Fair Value
18.1% upsideUndervalued by 18.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.54 Billion |
|---|---|
| Enterprise Value | $4.14 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.06 |
| Beta | 0.34 |
| Outstanding Shares | 46,403,350 |
Return
| Return on Equity | 6.24% |
|---|---|
| Return on Assets | 4.59% |
| Return on Invested Capital | 6.13% |
Valuation & Multiples
| P/E Ratio | 143.12 |
|---|---|
| PEG | -4.24 |
| Price to Sales | 12.35 |
| Price to Book Ratio | 8.98 |
| Enterprise Value to Revenue | 10.42 |
| Enterprise Value to EBIT | 100.27 |
| Enterprise Value to Net Income | 123 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.27 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 5, 2026
EPS Estimate
$0.18
Average shareholder expectationRevenue Estimate
$109.22 M
Average shareholder expectationNext Earnings Call
Expected Date
October 6, 2026
EPS Estimate
$0.16
Average shareholder expectationRevenue Estimate
$116.13 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 1.1130▼ 135.85% |
|---|---|
| Total Calls | 71,700▲ 271.50% |
| Total Puts | 79,800▲ 67.30% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 33.18%▲ 8.49% |
|---|---|
| Total Invested | $1.83B▲ 109.65% |
| Investors Holding | 164▲ 70.00% |
ESG Score
No data
About BillionToOne, Inc.
620 employees
CEO: Oguzhan Atay BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to...